Schizophrenia (Q55868331)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19700006%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

review article

1 reference

title

Schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19700006%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19700006%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Shitij Kapur

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19700006%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

English

0 references

publication date

1 August 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19700006%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19700006%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

374

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19700006%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

9690

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19700006%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

635-645

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19700006%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

A Systematic Review of Mortality in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

The Roscommon Family Study. II. The risk of nonschizophrenic nonaffective psychoses in relatives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

A twin study of genetic relationships between psychotic symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Are psychotic psychopathology and neurocognition orthogonal? A systematic review of their associations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Structure and Course of Positive and Negative Symptoms in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Madness explained: why we must reject the Kraepelinian paradigm and replace it with a 'complaint-orientated' approach to understanding mental illness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

A salience dysregulation syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Acceptable terminology and subgroups in schizophrenia: an exploratory study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Schizophrenia: a concise overview of incidence, prevalence, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Sex and Schizophrenia: Effects of Diagnostic Stringency, and Associations with Premorbid Variables

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Lifetime prevalence of psychotic and bipolar I disorders in a general population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Male gender is associated with deficit schizophrenia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Influence of diagnostic classification on gender ratio in schizophrenia - a meta-analysis of youths hospitalized for psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Obstetric complications and schizophrenia: historical and meta-analytic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Higher risk of offspring schizophrenia following antenatal maternal exposure to severe adverse life events

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Prenatal infection as a risk factor for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Prenatal nutritional deficiency and risk of adult schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

The antecedents of schizophrenia: a review of birth cohort studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Premorbid IQ in schizophrenia: a meta-analytic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Development of social functioning in preschizophrenia children and adolescents: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

A longitudinal study of premorbid IQ Score and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

1 reference

7 January 2021

Schizophrenia and urbanicity: a major environmental influence--conditional on genetic risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Schizophrenia and migration: a meta-analysis and review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Incidence of schizophrenia in ethnic minorities in London: ecological study into interactions with environment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Ethnic density of neighborhoods and incidence of psychotic disorders among immigrants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Cannabis, the mind and society: the hash realities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Familial Predisposition for Psychiatric Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Cumulative social disadvantage, ethnicity and first-episode psychosis: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Studying and treating schizophrenia using virtual reality: a new paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Experience sampling research in psychopathology: opening the black box of daily life

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

A cognitive model of the positive symptoms of psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Relationships between trauma and psychosis: a review and integration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Individual and familial risk factors for bipolar affective disorders in Denmark

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Strong association of de novo copy number mutations with autism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Rare chromosomal deletions and duplications increase risk of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Large recurrent microdeletions associated with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Disruption of the neurexin 1 gene is associated with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Support for the involvement of large copy number variants in the pathogenesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Phenotypic variations on the theme of CNVs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Identification of loci associated with schizophrenia by genome-wide association and follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

DNA methylation profiles in monozygotic and dizygotic twins.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Paternal ages below or above 35 years old are associated with a different risk of schizophrenia in the offspring

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Schizophrenia aetiology: do gene-environment interactions hold the key?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Heritability of brain morphology related to schizophrenia: a large-scale automated magnetic resonance imaging segmentation study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Genes making one feel blue in the flow of daily life: a momentary assessment study of gene-stress interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Brain volumes in relatives of patients with schizophrenia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Is the P300 wave an endophenotype for schizophrenia? A meta-analysis and a family study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Substantial genetic overlap between neurocognition and schizophrenia: genetic modeling in twin samples

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Emotional reactivity to daily life stress in psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Recovery from schizophrenia: with views of psychiatrists, psychologists, and others diagnosed with this disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

From being a disorder to dealing with life: an experiential exploration of the association between trauma and psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Prognosis in schizophrenia. Prognostic predictors and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Long-term Prognosis and Followup in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Catamnestic long-term study on the course of life and aging of schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Prognostic implications of the sex of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Outcome study of first-episode psychosis. I: Relapse rates after 1 year

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Early manifestations and first-contact incidence of schizophrenia in different cultures. A preliminary report on the initial evaluation phase of the WHO Collaborative Study on determinants of outcome of severe mental disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

The natural history of schizophrenia: a five-year follow-up study of outcome and prediction in a representative sample of schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

The Scottish first episode schizophrenia study. VII. Two-year follow-up. Scottish Schizophrenia Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Ten-year course of schizophrenia--the Madras longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

The course of schizophrenia over 13 years. A report from the International Study on Schizophrenia (ISoS) coordinated by the World Health Organization.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Symptoms at index admission as predictor for 1-5 year outcome in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

A 16-year follow-up study of schizophrenia and related disorders in Sofia, Bulgaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Cantabria first-episode schizophrenia study: three-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Neurocognitive function and outcome in first-episode schizophrenia: a 10-year follow-up of an epidemiological cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

A systematic review of longitudinal outcome studies of first-episode psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Meta-analysis of diffusion tensor imaging studies in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Neurobiology of dopamine in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

How antipsychotics work-from receptors to reality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Neurofunctional correlates of vulnerability to psychosis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

P50 sensory gating ratios in schizophrenics and controls: a review and data analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Perceiving is believing: a Bayesian approach to explaining the positive symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Multiple Dopamine Functions at Different Time Courses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

1 reference

7 January 2021

The formation of abnormal associations in schizophrenia: neural and behavioral evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Do patients with schizophrenia exhibit aberrant salience?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

How antipsychotics become anti-"psychotic"--from dopamine to salience to psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Hopping, skipping or jumping to conclusions? Clarifying the role of the JTC bias in delusions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Endophenotypes in schizophrenia: a selective review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Half a century of antipsychotics and still a central role for dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Emerging drugs for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Interventions to improve medication adherence in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

A systematic review of home treatment services--classification and sustainability.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

FACT: a Dutch version of ACT.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Use of intensive case management to reduce time in hospital in people with severe mental illness: systematic review and meta-regression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Stigmatization as an environmental risk in schizophrenia: a user perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Global pattern of experienced and anticipated discrimination against people with schizophrenia: a cross-sectional survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Adverse Subjective Experience With Antipsychotics and Its Relationship to Striatal and Extrastriatal D 2 Receptors: a PET Study in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Clinical interventions for treatment non-adherence in psychosis: meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

The effectiveness of supported employment for people with severe mental illness: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or cul-de-sac?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Vocational rehabilitation in schizophrenia and other psychotic disorders: a literature review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

A meta-analysis of cognitive remediation in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

The DEBIT trial: an intervention to reduce antipsychotic polypharmacy prescribing in adult psychiatry wards - a cluster randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Pharmacotherapy of schizophrenia with comorbid substance use disorder--reviewing the evidence and clinical recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Psychosocial interventions for people with both severe mental illness and substance misuse

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Early Intervention for psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness: the OPUS trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Monitoring and care of young people at incipient risk of psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Children's Self-Reported Psychotic Symptoms and Adult Schizophreniform Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

The incidence and outcome of subclinical psychotic experiences in the general population.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Putatively psychosis-prone subjects 10 years later

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

A decision analysis model to assess the feasibility of the early detection of psychosis in the general population.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

The empirical status of the ultra high-risk (prodromal) research paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

A meta-analysis of cognitive deficits in adults with a diagnosis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Longitudinal studies of cognition in schizophrenia: meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960995-8

7 January 2021

Assertive community treatment for people with severe mental disorders.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD001089

Identifiers

DOI

10.1016/S0140-6736(09)60995-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19700006%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference